Search: onr:"swepub:oai:lup.lub.lu.se:82d5715f-a1f4-412d-912b-14b77f3e0563" >
Simvastatin decreas...
Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury
-
McAuley, Daniel F. (author)
-
O'Kane, Cecilia M. (author)
-
Craig, Thelma R. (author)
-
show more...
-
Shyamsundar, Murali (author)
-
- Herwald, Heiko (author)
- Lund University,Lunds universitet,Infektionsmedicin,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Infection Medicine (BMC),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine
-
Dib, Karim (author)
-
show less...
-
(creator_code:org_t)
- 2013-07-19
- 2013
- English.
-
In: BMC Pulmonary Medicine. - : Springer Science and Business Media LLC. - 1471-2466. ; 13
- Related links:
-
https://portal.resea... (primary) (free)
-
show more...
-
http://dx.doi.org/10... (free)
-
https://bmcpulmmed.b...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Background: Heparin-binding protein is released by neutrophils during inflammation and disrupts the integrity of the alveolar and capillary endothelial barrier implicated in the development of acute lung injury and systemic organ failure. We sought to investigate whether oral administration of simvastatin to patients with acute lung injury reduces plasma heparin-binding protein levels and improves intensive care unit outcome. Methods: Blood samples were collected from patients with acute lung injury with 48 h of onset of acute lung injury (day 0), day 3, and day 7. Patients were given placebo or 80 mg simvastatin for up to 14 days. Plasma heparin-binding protein levels from patients with acute lung injury and healthy volunteers were measured by ELISA. Results: Levels of plasma heparin-binding protein were significantly higher in patients with acute lung injury than healthy volunteers on day 0 (p = 0.011). Simvastatin 80 mg administered enterally for 14 days reduced plasma level of heparin-binding protein in patients. Reduced heparin-binding protein was associated with improved intensive care unit survival. Conclusions: A reduction in heparin-binding protein with simvastatin is a potential mechanism by which the statin may modify outcome from acute lung injury.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Keyword
- Acute lung injury
- Simvastatin
- Heparin-binding protein
- Inflammation
- Neutrophils
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database